Company information:
Amphista Therapeutics Limited (No: 11119959)
Address: THE CORI BUILDING GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, CB21 6GQ, ENGLAND
Status: Active
Incorporated: 20-Dec-2017
Accounts Next Due: 30-Sep-2024
Next Confirmation Statement Due: 20-Dec-2024
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: JOSHUA BRUMM ( DOB: Dec-1977 From: Sep-2021 )
Current Director: ALESSIO CIULLI ( DOB: Jul-1977 From: Dec-2017 )
Current Director: BART DZIKOWSKI ( DOB: Mar-1976 From: Apr-2023 )
Current Director: CHRISTIAN BILLY JUNG ( DOB: Sep-1982 From: Dec-2022 )
Current Director: CHRISTIAN BILLY JUNG ( DOB: Sep-1982 From: Dec-2022 )
Current Director: CHRISTIAN BILLY JUNG ( DOB: Sep-1982 From: Dec-2022 )
Current Director: RAJESH PAREKH ( DOB: Jul-1960 From: Dec-2017 )
Current Director: RAJESH PAREKH ( DOB: Jul-1960 From: Dec-2017 )
Current Director: DOMINIC SCHMIDT ( DOB: Feb-1982 From: May-2022 )
Current Director: DOMINIC SCHMIDT ( DOB: Feb-1982 From: May-2022 )
Resigned Director: SATISH JINDAL ( DOB: Nov-1955 From: Mar-2020 To: Sep-2021 )
Resigned Director: FLORIAN MUELLERSHAUSEN ( DOB: Dec-1972 From: Mar-2021 To: Apr-2023 )
Resigned Director: RAJESH BHIKHU PAREKH ( DOB: Jul-1960 From: Dec-2017 To: May-2022 )
Resigned Director: RAJESH BHIKHU PAREKH ( DOB: Jul-1960 From: Dec-2017 To: May-2022 )
Resigned Director: IYONA RAJKOMAR ( From: Dec-2017 To: Jan-2019 )
Resigned Director: NICOLA THOMPSON ( DOB: Apr-1964 From: Jun-2019 To: Sep-2023 )
Persons of Significant Control:
Advent Life Sciences Fund Ii Lp, 27 Fitzroy Square, London, W1T 6ES, United Kingdom: Has significant influence or control (Notified: 2019-06-28, Ceased: 2019-06-28)
Advent Life Sciences Fund Ii Lp, 158-160 North Gower Street, London, NW1 2ND, England: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2017-12-20, Ceased: 2017-12-20)
Advent Life Sciences Llp, 158-160 North Gower Street, London, NW1 2ND, England: Ownership of shares – More than 25% but not more than 50% (Notified: 2017-12-20, Ceased: 2018-02-27)
Advent Life Sciences Llp, 27 Fitzroy Square, London, W1T 6ES, United Kingdom: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2019-06-28, Ceased: 2022-12-12)
Dr Alessio Ciulli, 158-160 North Gower Street, London, NW1 2ND, England: Ownership of shares – More than 25% but not more than 50% (Notified: 2018-02-27, Ceased: 2019-06-28)
Company Accounts Summary (£)
| Item | 2020-12-31 | 2021-12-31 | Chart |
|---|---|---|---|
| Called up share capital not paid, not expressed as current asset | 0.0,0.0 | ||
| Fixed assets | 720,094 | 880,915 | 720094.0,880915.0 |
| Fixed assets / Intangible assets | 297,500 | 262,500 | 297500.0,262500.0 |
| Fixed assets / Property, plant and equipment | 422,594 | 618,415 | 422594.0,618415.0 |
| Fixed assets / Investments, fixed assets | 0.0,0.0 | ||
| Current assets | 1,450,302 | 24,457,221 | 1450302.0,24457221.0 |
| Current assets / Total inventories | 0.0,0.0 | ||
| Current assets / Debtors | 0.0,0.0 | ||
| Current assets / Current asset investments | 3,000,000 | 0.0,3000000.0 | |
| Current assets / Cash at bank and on hand | 1,450,302 | 21,457,221 | 1450302.0,21457221.0 |
| Prepayments and accrued income, not expressed within current asset subtotal | 1,066,752 | 1,723,381 | 1066752.0,1723381.0 |
| Net current assets (liabilities) | 337,954 | -5,533,757 | 337954.0,-5533757.0 |
| Total assets less current liabilities | 1,058,048 | -4,652,842 | 1058048.0,-4652842.0 |
| Net assets (liabilities) | 1,058,048 | -4,652,842 | 1058048.0,-4652842.0 |
| Equity / share capital and reserves | 1,058,048 | 4,652,842 | 1058048.0,4652842.0 |